NCT03251716View on ClinicalTrials.gov

Berberine Treat Metabolic Syndrome in Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

October 30, 2017

Study Completion Date

December 30, 2017

Conditions
Metabolic SyndromeFemaleSchizophrenia
Interventions
DRUG

berberine

berberine 300mg TID add-on for berberine adjunctive group

Trial Locations (1)

300222

Tianjin Anding Hospital, Tianjin

All Listed Sponsors
lead

Tianjin Anding Hospital

OTHER

NCT03251716 - Berberine Treat Metabolic Syndrome in Schizophrenia | Biotech Hunter | Biotech Hunter